U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 202012

Expand all

EPROSARTAN MESYLATE (EPROSARTAN MESYLATE)
EQ 400MG BASE
Marketing Status: Discontinued
Active Ingredient: EPROSARTAN MESYLATE
Proprietary Name: EPROSARTAN MESYLATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 400MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A202012
Product Number: 001
Approval Date: Nov 16, 2011
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
EPROSARTAN MESYLATE (EPROSARTAN MESYLATE)
EQ 600MG BASE
Marketing Status: Discontinued
Active Ingredient: EPROSARTAN MESYLATE
Proprietary Name: EPROSARTAN MESYLATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 600MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A202012
Product Number: 002
Approval Date: Nov 16, 2011
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
Back to Top